-+ 0.00%
-+ 0.00%
-+ 0.00%

PureTech Health to Launch Phase 3 Trial of Deupirfenidone for Idiopathic Pulmonary Fibrosis

Reuters·12/08/2025 07:00:26

Please log in to view news